安易加速器-安易vp加速器官网-安易加速器官网入口-安易加速器
安易加速器-安易vp加速器官网-安易加速器官网入口-安易加速器
Applied BioMath specializes in mechanistic, mathematical modeling and simulation to provide quantitative and predictive guidance to biotechnology and pharmaceutical companies. We bring our expansive mathematical expertise, deep understanding of biology related to many therapeutic and disease areas, and industry experience to your specific project.
Learn more >
安易加速器-安易vp加速器官网-安易加速器官网入口-安易加速器
安易加速器-安易vp加速器官网-安易加速器官网入口-安易加速器
A rigorous fit-for-purpose model development process which quantitatively integrates knowledge about therapeutics with an understanding of its mechanism of action in the context of human disease mechanisms.
Learn More
安易加速器-安易vp加速器官网-安易加速器官网入口-安易加速器
Over 100 years of cumulative industry experience spanning the entire therapeutic workflow from early research to clinical pharmacology and regulatory filings.
Learn More
安易加速器-安易vp加速器官网-安易加速器官网入口-安易加速器
Our modeling process, proprietary technology, and high-performance computing allow us to conduct large-scale simulations quickly and accurately, without having to take unnecessary shortcuts on the biology or the mathematics.
Lantern官方网站
安易加速器-安易vp加速器官网-安易加速器官网入口-安易加速器
安易加速器-安易vp加速器官网-安易加速器官网入口-安易加速器
安易加速器-安易vp加速器官网-安易加速器官网入口-安易加速器
Interdisciplinary Teams
安易加速器-安易vp加速器官网-安易加速器官网入口-安易加速器
The goal of this collaboration was to develop a QSP model to support translation from preclinical to clinical studies, and first-in-human (FIH) studies and to use this QSP model to provide a deeper understanding of the mechanisms of hUGT1A1-modRNA and to guide design of the first-in-human clinical studies.